ArticleHaematologica2022

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.

Fredrik Schjesvold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.